Literature DB >> 27058219

Global prevalence of prothrombin gene mutation G20210A and implications in women's health: a systematic review.

Margaret Dziadosz1, Laxmi V Baxi.   

Abstract

Distribution of hereditary thrombophilic gene mutations differs globally. Prothrombin gene mutation G20210A is a common prothrombotic single-nucleotide polymorphism. In this systematic review, we provide a comprehensive report of the prevalence of prothrombin G20210A across the globe. Databases [Pubmed, Web of Science, Embase] were interrogated from their inception through December 2015 for articles reporting prothrombin G20210A prevalence rates and ethnicity. Prevalence rates were organized by continent and ethnoracial ancestry. A total of 113 articles were included with a total 61 876 participants tested for prothrombin G20210A. Reported prevalence rates varied from 0 to 15.9% among ethnic groups, with higher rates seen in the thromboembolism affected cohort compared with the unaffected cohort. Carrier rate distribution is supported by known historical migration patterns of global populations. This review of prothrombin G20210A prevalence may guide resourceful screening for identification of hereditary thrombophilia in female populations of interest with hypercoagulable states.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27058219     DOI: 10.1097/MBC.0000000000000562

Source DB:  PubMed          Journal:  Blood Coagul Fibrinolysis        ISSN: 0957-5235            Impact factor:   1.276


  3 in total

1.  Clinical and laboratory manifestations of the prothrombin gene mutation in women of reproductive age.

Authors:  A P Momot; M G Nikolaeva; N N Yasafova; M S Zainulina; K A Momot; I A Taranenko
Journal:  J Blood Med       Date:  2019-08-02

2.  Prevalence of thrombophilia-associated genetic risk factors in blood donors of a regional hospital in southern Brazil.

Authors:  Jéssica Dick-Guareschi; Juliana Cristine Fontana; Maria Teresa Vieira Sanseverino; Francyne Kubaski; Leo Sekine; Nanci Félix Mesquita; Tor Gunnar Hugo Onsten; Sandra Leistner-Segal
Journal:  Hematol Transfus Cell Ther       Date:  2021-03-16

3.  Examination of in Factor V Leiden and Prothrombin II Thrombophilic Mutations in Czech Young Women Using ddPCR-Prevalence and Cost-Benefit Analysis.

Authors:  Petra Riedlova; Dagmar Kramna; Silvie Ostrizkova; Hana Tomaskova; Vitezslav Jirik
Journal:  Healthcare (Basel)       Date:  2021-11-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.